Search research articles
Contact Us
Filters
Showing results (501-510 of 573) with videos related to
Page
of 58
Sort By:
American Heart Journal
|
June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial
Roberto Bolli, Joshua M Hare, Timothy D Henry, et al.
Journal of the American College of Cardiology
|
August 13, 2016
Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction
Sunil V Rao, Uwe Zeymer, Pamela S Douglas, et al.
JACC. Cardiovascular Interventions
|
October 20, 2022
Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic Shock
Abdulla A Damluji, Behnam Tehrani, Shashank S Sinha, et al.
Circulation. Cardiovascular Interventions
|
June 6, 2018
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)
Usman Baber, Shawn X Li, Rebecca Pinnelas, et al.
Circulation. Cardiovascular Interventions
|
April 19, 2019
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention
Michela Faggioni, Usman Baber, Samantha Sartori, et al.
American Heart Journal
|
March 22, 2019
Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study
Matthew T Finn, Björn Redfors, Dimitri Karmpaliotis, et al.
International Journal of Cardiology
|
January 2, 2017
Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents
Philippe Généreux, Björn Redfors, Bernhard Witzenbichler, et al.
Journal of the American Heart Association
|
December 24, 2022
On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DES
Bahira Shahim, Björn Redfors, Thomas D Stuckey, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
January 19, 2019
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes
Michela Faggioni, Usman Baber, Jaya Chandrasekhar, et al.
The American Journal of Cardiology
|
August 6, 2017
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry)
Mikkel Schoos, Jaya Chandrasekhar, Usman Baber, et al.
Page
of 58
Search research articles
Search
Showing results (501-510 of 573) with videos related to
Sort By:
Page
of 58
American Heart Journal
|
June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial
Roberto Bolli, Joshua M Hare, Timothy D Henry, et al.
Journal of the American College of Cardiology
|
August 13, 2016
Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction
Sunil V Rao, Uwe Zeymer, Pamela S Douglas, et al.
JACC. Cardiovascular Interventions
|
October 20, 2022
Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic Shock
Abdulla A Damluji, Behnam Tehrani, Shashank S Sinha, et al.
Circulation. Cardiovascular Interventions
|
June 6, 2018
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)
Usman Baber, Shawn X Li, Rebecca Pinnelas, et al.
Circulation. Cardiovascular Interventions
|
April 19, 2019
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention
Michela Faggioni, Usman Baber, Samantha Sartori, et al.
American Heart Journal
|
March 22, 2019
Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study
Matthew T Finn, Björn Redfors, Dimitri Karmpaliotis, et al.
International Journal of Cardiology
|
January 2, 2017
Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents
Philippe Généreux, Björn Redfors, Bernhard Witzenbichler, et al.
Journal of the American Heart Association
|
December 24, 2022
On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DES
Bahira Shahim, Björn Redfors, Thomas D Stuckey, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
January 19, 2019
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes
Michela Faggioni, Usman Baber, Jaya Chandrasekhar, et al.
The American Journal of Cardiology
|
August 6, 2017
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry)
Mikkel Schoos, Jaya Chandrasekhar, Usman Baber, et al.
Page
of 58